Vaccine Developer Files Ch. 11 Sale Plan With $11.5M Bid

By Vince Sullivan · February 18, 2025, 6:13 PM EST

Omega Therapeutics, which develops mRNA vaccines, filed proposed bidding procedures in Delaware bankruptcy court, saying it hopes to get a sale approved by mid-April and has a stalking-horse bid in hand...

To view the full article, register now.